# Rocket Pharmaceuticals, Inc.: Form 8-K, filed Jan 28, 2025

- Company: [Rocket Pharmaceuticals, Inc.](/companies/rckt.md) (CIK 1281895)
- Form: 8-K
- Filed: 2025-01-28
- Accepted by EDGAR: Jan 27, 2025, 21:28 ET
- Period: 2025-01-25
- Accession: 0001140361-25-002103
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1281895/000114036125002103/ef20042399_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1281895/000114036125002103/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1281895/000114036125002103/ef20042399_8k.htm

Filed Jan 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-002103. Last ingested by Listed: Nov 5, 2026, 15:30 ET. No prices; not investment advice.